AMORCYTE INC has a total of 26 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), Japan and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are PEVION BIOTECH AG, CLIO INC and CAR T SHANGHAI BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Japan | 4 | |
#3 | Canada | 3 | |
#4 | United States | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Israel | 2 | |
#7 | South Africa | 2 | |
#8 | Brazil | 1 | |
#9 | China | 1 | |
#10 | United Kingdom | 1 | |
#11 | Hong Kong | 1 | |
#12 | Malaysia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Preti Robert A | 17 |
#2 | Pecora Andrew L | 17 |
#3 | Pecora Andrew | 7 |
#4 | Preti Robert | 6 |
#5 | Pretti Robert | 1 |
Publication | Filing date | Title |
---|---|---|
US2012076760A1 | Compositions and methods of vascular injury repair | |
CA2778664A1 | Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency | |
CN102245189A | Infarct area perfusion-improving compositions and methods of vascular injury repair | |
MY147516A | Compositions and method of vascular injury repair cross-reference to related applications |